Reactions Weekly

, Volume 1734, Issue 1, pp 276–276 | Cite as


Various toxicities: 5 case reports
Case report


  1. Lenti MV, et al. A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study. Digestive and Liver Disease 50: 1299-1304, No. 12, Dec 2018. Available from: URL: - UnitedKingdom

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations